Compare SOC & IVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SOC | IVA |
|---|---|---|
| Founded | 2020 | 2011 |
| Country | United States | France |
| Employees | N/A | 77 |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 713.8M | 737.1M |
| IPO Year | 2021 | 2020 |
| Metric | SOC | IVA |
|---|---|---|
| Price | $3.62 | $2.88 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 12 |
| Target Price | $9.33 | ★ $15.20 |
| AVG Volume (30 Days) | ★ 7.1M | 2.3M |
| Earning Date | 11-12-2026 | 09-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 54.61 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $82.49 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.88 | $3.10 |
| 52 Week High | $19.25 | $7.98 |
| Indicator | SOC | IVA |
|---|---|---|
| Relative Strength Index (RSI) | 38.17 | 28.60 |
| Support Level | $3.28 | N/A |
| Resistance Level | $5.38 | $4.80 |
| Average True Range (ATR) | 0.28 | 0.24 |
| MACD | 0.03 | -0.02 |
| Stochastic Oscillator | 27.79 | 0.58 |
Sable Offshore Corp is a Houston-based independent upstream company focused on developing the Santa Ynez Unit in federal waters offshore California. The company operates as one reportable oil and gas segment and is engaged in the acquisition, development, exploration, and production of oil and natural gas.
Inventiva SA is a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and other diseases with unmet medical needs.